-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ElEnh3bH80+8sDFdHrtQNp4wO7iTDoCtnAHnKDkr8oSJgeHmnkw5CX0ndvsRO5d9 fSrOm2RVxIsB/VuejzW0dQ== 0001483806-10-000001.txt : 20100225 0001483806-10-000001.hdr.sgml : 20100225 20100225155054 ACCESSION NUMBER: 0001483806-10-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20100225 DATE AS OF CHANGE: 20100225 EFFECTIVENESS DATE: 20100225 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AETHLON MEDICAL INC CENTRAL INDEX KEY: 0000882291 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 133632859 STATE OF INCORPORATION: NV FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-88229-1L FILM NUMBER: 10633527 BUSINESS ADDRESS: STREET 1: 3030 BUNKER HILL STREET, #4000 CITY: SAN DIEGO STATE: CA ZIP: 92109 BUSINESS PHONE: 858-459-7800 MAIL ADDRESS: STREET 1: 3030 BUNKER HILL STREET, #4000 CITY: SAN DIEGO STATE: CA ZIP: 92109 FORMER COMPANY: FORMER CONFORMED NAME: BISHOP EQUITIES INC DATE OF NAME CHANGE: 19930602 D 1 primary_doc.xml X0603 D LIVE 0000882291 AETHLON MEDICAL INC 8910 University Center Lane, Suite 660 San Diego CA 92122 858-459-7800 NEVADA BISHOP EQUITIES INC Corporation true James A. Joyce 8910 University Center Lane, Suite 660 San Diego CA 92122 Executive Officer Director Richard H. Tullis 8910 University Center Lane, Suite 660 San Diego CA 92122 Executive Officer Director Franklyn S. Barry, Jr. 8910 University Center Lane, Suite 660 San Diego CA 92122 Director Edward G. Broenniman 8910 University Center Lane, Suite 660 San Diego CA 92122 Director Biotechnology No Revenues 06 false 2010-02-12 false true true true false 0 600000 600000 0 The investor received a $660,000 principal amount note and a warrant to acquire 660,000 shares of our common stock for a total purchase price of $600,000, of which we received $300,000 in cash and $300,000 in the form of a secured note from the investor. false 1 0 0 0 false AETHLON MEDICAL INC /s/ James A. Joyce James A. Joyce Chief Executive Officer 2010-02-25 -----END PRIVACY-ENHANCED MESSAGE-----